In 2017, the CONSORT-CHM Formulas 2017 extension was introduced to enhance the reporting transparency of randomized ...

The clinical trial was conducted at ten study centers in Spain and Russia between October 2020 ... More information: Maria ...

AC Immune SA has reported encouraging interim results from its phase 2 VacSYn clinical trial of ACI-7104.056, an ...

Before propensity matching, mothers of tetracycline-exposed infants were more often in the youngest and oldest age strata and ...

A new drug strategy that regulates the tumor immune microenvironment may transform a tumor that resists immunotherapy into a ...

Net Loss: Net loss attributable to common stockholders for the third quarter of 2024 was $ (3.1) million, or $ (1.92) per ...

Eli Lilly has reported comprehensive outcomes from the SURMOUNT-1 study of tirzepatide for treating pre-diabetic and obese ...

After two trials and six years in prison, former Molly’s Pub owner Anthony Maglietta had his 2015 assault conviction ...

Three years after the movie was struck by tragedy, its director and new cinematographer explain how they battled through ...

In a small subset of those patients, the combination resulted in a strong response with tumor shrinkage and no disease ...

A new BLA for datopotamab deruxtecan aims for FDA accelerated approval to treat EGFR-mutated NSCLC based on data from ...

After a research note raised potential safety concerns with Amgen's lead obesity candidate, the company defended its drug and ...